Hola,
Are you new here?

I have an account

¿Te ayudamos?

Ejemplos de búsqueda

Vídeos Explicativos

HISCREENDIAG

financed

Closed

Building a Tool to Evaluate and Improve Health Investments in Screening and Diag...

Building a Tool to Evaluate and Improve Health Investments in Screening and Diagnosis of disease Over recent decades, the possibilities for the prevention, diagnosis and treatment of disease have expanded throughout the EU. As a result, health policy decision makers and public funders are faced with the challenge of making ch... see more

28/02/2011

UGent

473K€

Project Budget: 473K€

Project leader

UNIVERSITEIT GENT No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

PARTICIPATION DEPralty Sin fecha límite de participación.

Ver 6 Participantes

Financing granted El organismo FP7 notifico la concesión del proyecto The day 2011-02-28 We do not have the information of the call

0% 93% 100%

characteristics of the participant

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Private Information

No hay información privada compartida para este proyecto. Habla con el coordinador.

6 Participantes

UGent

0.00€ | Leader

RIJKSUNIVERSITEIT GRONINGEN

N.D. | participant

BELSPO

N.D. | participant

UNIVERSITY OF MANCHESTER

N.D. | participant

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Project leader

UNIVERSITEIT GENT No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Project Budget 473K€

participation deadline Sin fecha límite de participación.

Project description Over recent decades, the possibilities for the prevention, diagnosis and treatment of disease have expanded throughout the EU. As a result, health policy decision makers and public funders are faced with the challenge of making choices for health investments to improve the healthy life expectancy of Europeans within the context of constrained resources. Health investments include any new technology for the diagnosis, prevention or treatment of disease. It is not clear to which extent recent decisions on such health investments have been optimal. Public funders sometimes evaluate the impact of health investments, but there is a lack of standardised procedures and criteria. This is even more the case for investments related to screening and diagnosis of disease, and in particular gene technologies. The objectives of this study are: 1. to set up a set of common criteria (a ‘tool’) for the evaluation of health investments related to screening and diagnosis (HISD) in Europe, with a special focus on gene technologies; 2. to guide the better alignment of procedures between all (old and new) MS; and 3. to improve the effectiveness and cost-effectiveness of future HISD. Literature reviews will identify existing methods for evaluating health investments and summarise existing procedures and criteria within member states (MS) for making and evaluating decisions on HISD. In parallel, stakeholders will be invited to participate in a survey allowing a better understanding of the commonalities and differences between MS. Based on this, a draft tool, comprising procedures and criteria for evaluating HISD will be proposed. The draft tool will be assessed by a panel of experts guiding its iterative development. A list of recent HISD in MS will then serve as subject for testing the practical applicability of the tool. Finally, ways for implementing the tool and for the evaluation of HISD in MS will be proposed together with recommendations and political implications at EU level.

Conecta tu I+D

Entra hoy

Forgot your password?

Financing

Companies

CTIs/Universidades

Projects

researchers